Navigation Links
Big Pharma Dealmaking Activity Highlighted by CurrentPartnering in Comprehensive Report Published at MarketPublishers.com
Date:9/9/2013

London, UK (PRWEB) September 09, 2013

What are the leading big pharma companies? What does the company’s recent dealmaking activity look like? What are the key terms included in a partnering agreement? What are the key aspects of partnering? What are the predominant big pharma companies’ dealmaking trends over the last four years? How to assess a prospective partner’s flexibility? How to submit an opportunity to big pharma? How to determine under what terms a prospective partner agrees to a partnering relationship? How does the negotiation process look like? What are the key issues and aspects of the dealmaking? What is actually granted by the agreement to the partner company? How are disputes during the dealmaking process resolved? Which jurisdiction does the company insist upon for agreement law? The answers to all these questions and other essential information required to better understand big pharma partnering ?an be found in the report.

Comprehensive research report “Partnering Deals and Alliances with Big Pharma” worked out by CurrentPartnering has been recently published by Market Publishers Ltd.

Report Details:

Title: Partnering Deals and Alliances with Big Pharma
Published: July, 2013
Pages: 877
Price: US$ 2,995.00
http://marketpublishers.com/report/life_sciences/pharmaceuticals/partnering-deals-n-alliances-with-big-pharma.html

The report offers in-depth insights into the dealmaking interests and activity of the world’s top fifty big pharma companies by providing their comprehensive partnering activity profiles. It presents essential data on each of the companies’ partnering activities since 2007; presents a full listing of partnering deals by deal type, industry sector, phase of development, technology type and therapeutic area; grants comprehensive access to over 3,000 partnering deals together with contract documents if available. The research contains gives objective insights into the terms included in a partnering agreement, with real world clause examples; uncovers details on the forthcoming big pharma partnering events, and evaluates the big pharma future opportunities.

Reasons to Buy:

  • The report provides a reader with an in-depth understanding of the partnering activities of the leading fifty big pharma companies worldwide.
  • Comprehensive dealmaking profiles of the companies enable to understand the key aspects of the partnering deals and to prepare for making a successful contract.
  • The study helps to undertake the key deal terms as well as due diligence to assess suitability of proposed deal terms for partner companies.
  • Review of the company’s dealmaking activity during 2007-2013 assist in assessing and choosing the potential business partners.

More in-demand research studies by CurrentPartnering can be found at http://marketpublishers.com/members/currentpartner/info.html

About Us:

MarketPublishers.com is a multilingual hypermarket offering a rich collection of comprehensive studies on various markets, sectors, industries, companies, etc. We perform professional services aimed to equip our clients with high-quality research products and support critical decision-making.

Read the full story at http://www.prweb.com/releases/2013/9/prweb11102860.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Lawsuit Alleges Takeda Pharmaceutical Co., Maker of Diabetes Drug Actos, Didn’t Warn of the Drug’s Risks Soon Enough; Parker Waichman LLP Responds
2. Targeted Medical Pharma Initiates Clinical Trial of Red Blood Cell Stimulating Formulation
3. Global Pharmaceutical Packaging Market is Expected to Reach USD 73.04 Billion in 2018: Transparency Market Research
4. 67 Pharmaceutical Markets with 2013 Facts & Figures Reviewed in New Research Report at ReportsnReports.com
5. Pathways Pharmacist Denise Schoenberger Honored for Healthcare Excellence by Silicon Valley Business Journal
6. Drug Delivery Technology Pharmaceutical Market (Metered Dose Inhalers, Needle-Free Injectors) is Worth $224.2 Billion by 2017 - New Report by MarketsandMarkets
7. Leiter's Compounding Pharmacy Welcomes New Director of Marketing
8. World Radiopharmaceuticals Market to Reach USD 5.5bn in 2017, According to M&M Report Available at MarketPublishers.com
9. Phen375 Released The Newest Pharmacy-Grade Rapid Weight Loss Supplement
10. Could You Have Sleep Apnea? - Consumer Wellness Tips from Ritch's Pharmacy and HealthMart
11. Pharmaceutical Excipients Market Demand was 519.5 Kilo Tons in 2011 And is Expected to Reach 685.6 Kilo Tons in 2018 : Transparency Market Research
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2016)... ... December 02, 2016 , ... The PAINWeekEnd Regional Conference will ... Spa in Honolulu, offering local frontline clinicians the opportunity to extend their certified ... demand for supplemental training related to pain management has surged dramatically in recent ...
(Date:12/2/2016)... ... 2016 , ... Sourced from the Isbre Springs beneath the 5,000 year old ... purity of just 6 ppm TDS (Total Dissolved Solids) in addition to its excellent ... in several ShopRite and FoodTown stores in NJ and received rave comments from consumers. ...
(Date:12/2/2016)... (PRWEB) , ... December 02, 2016 , ... Yisrayl Hawkins, ... delves into how this current generation fits into Bible Prophecy. Yisrayl says this generation, ... facts pointing to this conclusion, showing how the details line up exactly with Bible ...
(Date:12/2/2016)... ... December 02, 2016 , ... Clarify Health Solutions, Inc., ... $6.0 million in an initial round of funding. The round was led by ... caregivers can receive far better care through the application of the best technologies ...
(Date:12/2/2016)... ... December 02, 2016 , ... Today CloudMine, ... connected applications, was named the best Sales Team of 2016 as part of ... made today by the Software & Information Industry Association (SIIA), the principal trade ...
Breaking Medicine News(10 mins):
(Date:12/2/2016)... 2016   CytoSorbents Corporation (NASDAQ: CTSO ... Union approved CytoSorb ® cytokine adsorber to treat ... announced that Dr. Phillip Chan , Chief Executive ... Micro Main Event investor conference held from December ... Sunset Boulevard Hotel in Los Angeles, California ...
(Date:12/2/2016)... 2016 On Thursday, the NASDAQ Composite ... Jones Industrial Average edged 0.36% higher, to finish at 19,191.93; ... were broad based as six out of nine sectors ended ... on the following Services equities: Myriad Genetics Inc. (NASDAQ: ... INC Research Holdings Inc. (NASDAQ: INCR ), and ...
(Date:12/2/2016)... Dec. 1, 2016 The concept of rare diseases ... given to this sector has been taking shape in ... the political aspects and initiatives related to orphan medicinal products ... the level of member states individually. Many member states in ... the space of orphan medicinal products, the result of which ...
Breaking Medicine Technology: